Literature DB >> 23661427

Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort.

Roberta Gonçalves Marangoni1, Luiza Fuoco Rocha, Ana Paula T Del Rio, Natalino H Yoshinari, João Francisco Marques-Neto, Percival D Sampaio-Barros.   

Abstract

OBJECTIVE: Systemic sclerosis sine scleroderma (ssSSc) is an infrequent SSc variant characterized by visceral and immunological manifestations of SSc in the absence of clinically detectable skin involvement. We sought to delineate the characteristics of ssSSc in a cohort of Brazilian patients and contrast them with those in the literature.
METHODS: SSc patients seen at two academic medical centres in Brazil were retrospectively analysed. Patients were classified as ssSSc if they presented with RP, positive ANAs and at least one visceral involvement typical of SSc in the absence of skin thickening. Demographics, clinical and laboratory data were obtained by chart review. Literature review was performed by searching available original studies up until June 2012.
RESULTS: Among the 947 consecutive patients with SSc, 79 (8.3%) were classified as ssSSc. Oesophagus was the most frequently affected organ (83.1%), followed by pulmonary involvement (63.2%). Compared with the limited cutaneous form of SSc, telangiectasia was the only variable significantly different after multivariate logistic regression analyses (odds ratio 0.46; 95% CI 0.27, 0.81). Compared with the diffuse cutaneous form of SSc, multivariate analyses revealed that ssSSc patients were less likely to be male (odds ratio 0.15; 95% CI 0.04, 0.57), have digital ulcers (odds ratio 0.26; 95% CI 0.13, 0.51) or anti-Scl70 antibodies (odds ratio 0.19; 95% CI 0.07, 0.55) and less frequently treated with CYC (odds ratio 0.23; 95% CI 0.12, 0.43). These features were comparable to those in the published literature.
CONCLUSION: In this series, patients with ssSSc had a relatively mild disease with good prognosis.

Entities:  

Keywords:  epidemiology; systemic sclerosis sine scleroderma

Mesh:

Year:  2013        PMID: 23661427     DOI: 10.1093/rheumatology/ket163

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  8 in total

1.  Connective tissue diseases: systemic sclerosis: beyond limited and diffuse subsets?

Authors:  John Varga; Monique Hinchcliff
Journal:  Nat Rev Rheumatol       Date:  2014-02-18       Impact factor: 20.543

2.  Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes.

Authors:  Alain Lescoat; Susan L Murphy; David Roofeh; John D Pauling; Michael Hughes; Robert Sandler; François Zimmermann; Rachel Wessel; Whitney Townsend; Lorinda Chung; Christopher P Denton; Peter A Merkel; Virginia Steen; Yannick Allanore; Francesco Del Galdo; Dominique Godard; David Cella; Sue Farrington; Maya H Buch; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2020-10-05

3.  A 45-Year-Old Man with Scleroderma Renal Crisis Associated with a History of Systemic Sclerosis Sine Scleroderma.

Authors:  Panupong Hansrivijit; Kelechi F Omeonu; Halimat O Lawal; Mounika Gangireddy; Kinjal P Gadhiya; Ravinder S Dhatt
Journal:  Am J Case Rep       Date:  2020-11-24

4.  Osteopetrosis in a Patient of Systemic Sclerosis Sine Scleroderma: A Rare Association.

Authors:  Saroj K Pati; Praveen Raja; Ajoy K Behera; T G Ranganath; Narendra K Bodhey
Journal:  Indian J Radiol Imaging       Date:  2022-01-10

5.  Systemic sclerosis sine scleroderma in children.

Authors:  Francesco Zulian; Gloria Lanzoni; Biagio Castaldi; Alessandra Meneghel; Francesca Tirelli; Elisabetta Zanatta; Giorgia Martini
Journal:  Rheumatology (Oxford)       Date:  2022-05-30       Impact factor: 7.046

Review 6.  Interpretation of autoantibody positivity in interstitial lung disease and lung-dominant connective tissue disease.

Authors:  Daniel Antunes Silva Pereira; Alexandre de Melo Kawassaki; Bruno Guedes Baldi
Journal:  J Bras Pneumol       Date:  2013 Nov-Dec       Impact factor: 2.624

7.  Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death.

Authors:  C P Simeón-Aznar; V Fonollosa-Plá; Carles Tolosa-Vilella; G Espinosa-Garriga; M Campillo-Grau; M Ramos-Casals; F J García-Hernández; M J Castillo-Palma; J Sánchez-Román; J L Callejas-Rubio; N Ortego-Centeno; M V Egurbide-Arberas; L Trapiellla-Martínez; L Caminal-Montero; L Sáez-Comet; J Velilla-Marco; M T Camps-García; E de Ramón-Garrido; E M Esteban-Marcos; L Pallarés-Ferreres; N Navarrete-Navarrete; J A Vargas-Hitos; R Gómez de la Torre; G Salvador-Cervello; J J Rios-Blanco; M Vilardell-Tarrés
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

8.  Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody.

Authors:  Yusho Ishii; Hiroshi Fujii; Koichiro Sugimura; Tsuyoshi Shirai; Yosuke Hoshi; Yoko Fujita; Yuko Shirota; Tomonori Ishii; Hiroaki Shimokawa; Hideo Harigae
Journal:  Case Rep Rheumatol       Date:  2020-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.